Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Joseph, MO
NPI
1831120773
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
101 Mosaic Ct Ste 300
Saint Joseph, MO, 64506
Phone (816) 271-1343
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
2,229 services
Medicare patients, 2024
926
Average age 72
Drug cost, 2024
$3.4M
9,051 prescriptions
Company payments, 2025
$3,192
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Junping Yang was code 99214 (office e&m - established), 1,071 times for 662 patients. In total Junping Yang billed 2,229 services in 10 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,071 | 662 | $61.14 | $65K |
| 99233 Hospital E&M - Subsequent | Facility | 473 | 108 | $86.67 | $41K |
| 99443 Telephone Services | Office | 168 | 145 | $71.00 | $12K |
| 99214 Office E&M - Established | Office | 161 | 108 | $76.75 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 140 | 40 | $57.73 | $8,083 |
| 99223 Hospital E&M - Initial | Facility | 96 | 88 | $127.60 | $12K |
| 99204 Office E&M - New | Facility | 69 | 69 | $94.34 | $6,510 |
| 95251 Test - Miscellaneous | Facility | 25 | 11 | $25.00 | $625 |
By year: 2022 $153K for 2,280 services; 2023 $152K for 2,222 services; 2024 $161K for 2,229 services.
Medicare prescription drug claims, 2024
In 2024, the drug Junping Yang prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,217 prescriptions and refills. In total Junping Yang wrote 9,051 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,217 | 2,924 | 294 | $11K |
| Metformin Hcl Er Metformin Hcl | 480 | 1,236 | 137 | $4,571 |
| Metformin Hcl Generic | 453 | 1,104 | 117 | $6,188 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 451 | 1,038 | 163 | $104K |
| Ozempic Semaglutide | 370 | 502 | 73 | $467K |
| Glipizide Er Glipizide | 370 | 937 | 109 | $3,909 |
| Farxiga Dapagliflozin Propanediol | 256 | 549 | 65 | $309K |
| Januvia Sitagliptin Phosphate | 208 | 360 | 45 | $184K |
| Mounjaro Tirzepatide | 202 | 230 | 37 | $241K |
| Rosuvastatin Calcium Generic | 189 | 525 | 55 | $2,189 |
| Atorvastatin Calcium Generic | 185 | 447 | 49 | $1,701 |
| Jardiance Empagliflozin | 179 | 364 | 42 | $203K |
| Synthroid Levothyroxine Sodium | 157 | 358 | 37 | $14K |
| Humalog Kwikpen U-100 Insulin Lispro | 149 | 344 | 59 | $64K |
| Lisinopril Generic | 144 | 428 | 41 | $788 |
Brand drugs: 3,779 claims; generic drugs: 4,668 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Junping Yang $3,192 ($3,192 in general payments such as food, travel and fees) from 28 companies. The largest payer was Chiesi USA, Inc. with $950.
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 3 | $950 |
| CeQur Corporation | 1 | $422 |
| Amgen Inc. AMGN | 15 | $344 |
| Abbott Laboratories ABT | 12 | $180 |
| Novo Nordisk Inc NVO | 6 | $163 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $147 |
| Corcept Therapeutics CORT | 6 | $112 |
| Xeris Pharmaceuticals, Inc. | 5 | $87.41 |
| Dexcom, Inc. DXCM | 3 | $80.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.